Accolade Inc
NASDAQ:ACCD
Accolade Inc
Other Current Liabilities
Accolade Inc
Other Current Liabilities Peer Comparison
Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Accolade Inc
NASDAQ:ACCD
|
Other Current Liabilities
$57.8m
|
CAGR 3-Years
19%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Other Current Liabilities
$942.1m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-3%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Other Current Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
CVS Health Corp
NYSE:CVS
|
Other Current Liabilities
$2.4B
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
Cigna Corp
NYSE:CI
|
Other Current Liabilities
$33.3B
|
CAGR 3-Years
34%
|
CAGR 5-Years
24%
|
CAGR 10-Years
32%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Other Current Liabilities
$377.5m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
1%
|
CAGR 10-Years
47%
|
See Also
What is Accolade Inc's Other Current Liabilities?
Other Current Liabilities
57.8m
USD
Based on the financial report for Feb 28, 2023, Accolade Inc's Other Current Liabilities amounts to 57.8m USD.
What is Accolade Inc's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
30%
Over the last year, the Other Current Liabilities growth was 3%. The average annual Other Current Liabilities growth rates for Accolade Inc have been 19% over the past three years , 30% over the past five years .